Chemistry Service Platform - CRO in Medicinal Chemistry

Axon Ligands (TM) - alphabetic: [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]

 

 

 

  

AEE 788  -  NVP-AEE788

 

 

CAS 497839-62-0 

C27H32N6  MW 440.58

 Purity: 99% (optically pure)

Soluble in DMSO to 90 mM 

 

 

 

 

Ordering Information:

 

Cat. No. Axon 1653    Prime Source

 

Qty1: 5 mg (research smaple) / €135  $176

Promotion: 2 x 5 mg @ €200  $260

Qty2: 25 mg (research sample) / €475  $618

Promotion: 2 x 25 mg @ €660  $858

Qty3: on request

 

Send enquiry to: order@axonmedchem.com

or by fax to: +31-50-3600390.

 

Contact us for payment and tech support.

 

Biological Activity:

 

A dual family EGFR/ErbB2 and VEGFR kinase inhibitor with antitumor and antiangiogenic activity.

 

References:

 

P Traxier, PR Allegrini, R Brandt, et al. AEE788: A dual family EGFR/ErbB2 and VEGFR kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res. 2004, 64, 4931-4941. [online]

 

D Meco et al. Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma. Transl. Oncol. 2010, 3(5), 326-335. [online]

 

 

 

Chemical Name: (R)-6-[4-[(4-ethyl-1-piperazinyl)methyl]phenyl]-N-(1-phenylethyl)-7H-Pyrrolo[2,3-d]pyrimidin-4-amine

 

AEE 788 | EGFR/VEGFR inhibitor | Axon Medchem | Axon 1653 | NVP-AEE788

Axon Ligands TM - Research chemicals for biological study. Some high-profile samples could be provided under terms of contract research synthesis.

axonmedchem.com © 2012

 

Axon Ligands In The Field:

 

AEE 788 | EGFR/VEGFR inhibitor

BIBW 2992 | EGFR/HER2 inhibitor

Lapatinib | EGFR/HER2 inhibitor

Neratinib | EGFR/HER2 inhibitor

 

CI 1033 | EGFR inhibitor

CP 724714 | HER2 inhibitor

Erlotinib | EGFR inhibitor

Gefitinib | EGFR inhibitor

OSI 420 | EGFR inhibitor

Pelitinib | EGFR inhibitor

Vandetanib | VEGFR/EGFR inhibitor

WZ4002 | EGFR T790M inhibitor

 

 

Click Here To See Featured Cell Signaling and Oncology Ligands from Axon Ligands Collection